Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.

Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardern-Jones A, Murkin A, Dowe A, Kelly J, Williams S, Oram R, Stevens M, Teare DM, Ponder BA, Gayther SA, Easton DF, Eeles RA; Cancer Research UK/Bristish Prostate Group UK Familial Prostate Cancer Study Collaborators.; British Association of Urological Surgeons Section of Oncology..

Am J Hum Genet. 2003 Jan;72(1):1-12. Epub 2002 Dec 9.

2.

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.

Clin Cancer Res. 2002 Dec;8(12):3776-81.

3.

Cancer Incidence in BRCA1 mutation carriers.

Thompson D, Easton DF; Breast Cancer Linkage Consortium..

J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65.

PMID:
12237281
4.

A genetic profile of contemporary Jewish populations.

Ostrer H.

Nat Rev Genet. 2001 Nov;2(11):891-8. doi: 10.1038/35098506. Review.

PMID:
11715044
5.

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73.

6.

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

Thompson D, Easton D; Breast Cancer Linkage Consortium..

Am J Hum Genet. 2001 Feb;68(2):410-9. Epub 2001 Jan 19.

7.

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.

Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, Zehavi M, Sidi AA, Ramon Y, Tischler T, Livne PM, Friedman E.

Br J Cancer. 2000 Aug;83(4):463-6.

8.

A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes.

Kuperstein G, Foulkes WD, Ghadirian P, Hakimi J, Narod SA.

Clin Genet. 2000 Mar;57(3):213-20.

PMID:
10782928
9.

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.

Hubert A, Peretz T, Manor O, Kaduri L, Wienberg N, Lerer I, Sagi M, Abeliovich D.

Am J Hum Genet. 1999 Sep;65(3):921-4. No abstract available.

10.

Cancer risks in BRCA2 mutation carriers.

Breast Cancer Linkage Consortium..

J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6.

PMID:
10433620
11.

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S.

J Natl Cancer Inst. 1999 Jul 21;91(14):1241-7.

PMID:
10413426
12.

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

Nastiuk KL, Mansukhani M, Terry MB, Kularatne P, Rubin MA, Melamed J, Gammon MD, Ittmann M, Krolewski JJ.

Prostate. 1999 Aug 1;40(3):172-7.

13.

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.

Lehrer S, Fodor F, Stock RG, Stone NN, Eng C, Song HK, McGovern M.

Br J Cancer. 1998 Sep;78(6):771-3.

14.

BRCA2 mutation in Icelandic prostate cancer patients.

Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjörd JE, Jonsson E.

J Mol Med (Berl). 1997 Oct;75(10):758-61.

PMID:
9383000
15.

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, McManus R, Neuhausen SL, Ford D, Wooster R, Cannon-Albright LA, Stratton MR, Goldgar DE.

Am J Hum Genet. 1997 Jul;61(1):120-8.

16.

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA.

N Engl J Med. 1997 May 15;336(20):1401-8.

17.

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.

Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K.

Nat Genet. 1996 Oct;14(2):188-90.

PMID:
8841192
18.

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.

Roa BB, Boyd AA, Volcik K, Richards CS.

Nat Genet. 1996 Oct;14(2):185-7.

PMID:
8841191
19.

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE.

Lancet. 1994 Mar 19;343(8899):692-5.

PMID:
7907678
20.

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC.

Nat Genet. 1995 Oct;11(2):198-200. Erratum in: Nat Genet 1996 Jan;12(1):110.

PMID:
7550349

Supplemental Content

Support Center